Bookmark

Add to MyYahoo RSS

ImmunoGen News

News on ImmunoGen (Ticker: IMGN) continually updated from thousands of sources around the net.

Thursday Apr 17 | Freshnews

ImmunoGen, Inc. Announces Conference Call to Discuss its Third...

ImmunoGen, Inc . , a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate technology, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, April 25, 2014, to discuss ImmunoGen's financial results for the three-month period ended March 31, 2014.

Comment?

Related Topix: ImmunoGen, Biotech, Medicine, Healthcare Industry

Wed Apr 16, 2014

MarketNewsVideo

Wednesday Sector Leaders: Biotechnology, Rubber & Plastics

In trading on Wednesday, biotechnology shares were relative leaders, up on the day by about 2%.

Comment?

Related Topix: Biotech, Medicine, ImmunoGen, Healthcare Industry, Business News, Video

MarketNewsVideo

Wednesday's ETF Movers: FBT, GDX

In trading on Wednesday, the First Trust NYSE Arca Biotechnology Index Fund ETF is outperforming other ETFs, up about 2.6% on the day.

Comment?

Related Topix: Biotech, Medicine, ImmunoGen, Healthcare Industry, InterMune, Business News, Video

AmericanBankingNews.com

Immunogen Rating Reiterated by Canaccord Genuity

's stock had its "buy" rating reaffirmed by investment analysts at Canaccord Genuity in a note issued to investors on Wednesday, American Banking and Market News reports.

Comment?

Related Topix: ImmunoGen, Biotech, Medicine, Healthcare Industry

Tue Apr 08, 2014

Business Wire

ImmunoGen, Inc. Announces First Clinical Findings with Refined Dosing Strategy for IMGN853

The data were presented at the American Association for Cancer Research Annual Meeting in San Diego, CA.

Comment?

Related Topix: Biotech, Medicine, ImmunoGen, Healthcare Industry

Mon Apr 07, 2014

AmericanBankingNews.com

Immunogen Rating Increased to Outperform at Zacks

The firm currently has a $15.90 target price on the stock. Zacks 's price objective suggests a potential upside of 19.64% from the company's previous close.

Comment?

Related Topix: ImmunoGen, Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••